SUBSTITUTED TETRACYCLINE COMPOUNDS
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.
1 - 392 . (canceled)
393 . A substituted tetracycline compound of Formula (VIII):
wherein:
T is CR 7td ;
R 4 is alkylamino;
R 4′ is hydrogen;
R te is hydrogen;
R 7ta , R 7tb , and R 7tc are each independently hydrogen, halogen, hydroxyalkyl, hydroxyalkylaminocarbonyl, alkylaminoalkyloxy, aminocarbonyl, alkylaminoalkylaminocarbonyl, aminoalkylaminocarbon yl, methylpiperazinylcarbonyl, alkylaminocarbonyl, heteroarylalkylaminocarbonyl, alkoxycarbonylalkylaminocarbonyl, acylaminoalkylaminocarbonyl, alkoxyaminocarbonyl, alkoxyalkylaminocarbonyl or alkylaminoalkylcarbonylamino, or R 7tb and R 7tc are linked to form a ring; and
R 7td is hydroxyalkyl, alkylaminoalkylaminocarbonyl, dialkylaminoalkylaminocarbonyl, hydroxyalkylaminocarbonyl, aminoalkylaminocarbonyl, methylpiperazinylcarbonyl, heteroarylalkylaminocarbonyl, acylaminoalkylaminocarbonyl, or alkoxyalkylaminocarbonyl, or
a pharmaceutically acceptable salt thereof;
with the proviso that the compound of Formula (VIII) is not
or an enantiomer or diastereomer thereof.
394 . The compound of claim 393 , wherein R 7ta and R 7tc are each hydrogen.
395 . The compound of claim 393 , wherein one of R 7ta , R 7tb , and R 7tc is halogen.
396 . The compound of claim 395 , wherein R 7ta is halogen.
397 . The compound of claim 393 , wherein R 7tb and R 7tc are linked to form a ring.
398 . The compound of claim 393 , wherein R 7td is methylaminoalkylaminocarbonyl, dimethylaminoalkylaminocarbonyl, diethylaminoalkylaminocarbonyl, diisoproprylaminoalkylaminocarbonyl, pyrrolidinylalkylaminocarbonyl, piperidinylalkylaminocarbonyl, furanylalkylaminocarbonyl, ethoxycarbonylalkylaminocarbonyl, methoxyaminocarbonyl, or methoxyalkylaminocarbonyl.
399 . The compound of claim 393 , wherein the compound is represented by any one of the following structural formulas:
or a pharmaceutically acceptable salt thereof.